- Bristol Myers joins Hengrui party in 13-asset deal worth up to $15.2B Endpoints News
- Bristol Myers Squibb inks $15B biobucks deal to bag Hengrui assets, tap China’s R&D speed Fierce Biotech
- Bristol Myers Squibb partners with China’s Hengrui Pharma on a dozen drugs statnews.com
- Bristol-Myers Inks Up to $15 Billion Licensing Deal With Hengrui Bloomberg.com
- BMS, Hengrui strike $15.2B multi-asset pact FirstWord Pharma
